/Companies

Gestalt Diagnostics

Spokane, US · Founded 2015 · Washington corporation · 7 known investors

Find your way into Gestalt Diagnostics

Sign up to see every warm intro you have to Gestalt Diagnostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Gestalt Diagnostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Gestalt provides a vendor-neutral digital pathology platform and professional services that enable pathology laboratories and health systems to modernize workflows, integrate AI tools, and manage diagnostic imaging without vendor lock-in. The company serves enterprise hospitals, academic medical centers, and pathology groups seeking interoperable solutions across scanners, laboratory information systems, and AI applications.

Founders & leadership

SRSteve Rector
Steve RectorExecutivePartner at Cowles Ventures
KMKen McCabe
Ken McCabeExecutive
DR
Dan RoarkNamed on SEC filing

Board

BD
Bill DriscollBoard director
CP
Chris PatrickBoard director
OM
Octavio MoralesBoard director
JC
Jon CopelandBoard director
MC
Marco ChungBoard director

Investors · 7

Also in the syndicate · 3

Inland Imaging InvestmentsleadKickStart FundsleadTVF Fundslead

Reported raises · per SEC filings

Form D private placements

$9.6M disclosed across 3 rounds · 2017–2025

▶$6.7MraisedJul 2025 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill DriscollDirector
  • Chris PatrickDirector
  • Steve RectorExecutive Officer
  • Octavio MoralesDirector
  • Dan RoarkExecutive Officer, Director, Promoter
Offering amount
$9.3M
Amount sold
$6.7M
First sale
Mar 2025
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedJan 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ken McCabeDirector
  • Wayne WagerDirector
  • David HoakDirector
  • John BellDirector
  • Dan RoarkExecutive Officer, Director
  • Chris ZylakDirector
Offering amount
$2M
Amount sold
$300K
Minimum investment
$25K
First sale
Jan 2019
Incorporated
Limited Liability Company, Washington, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedMar 2017 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ken McCabeExecutive Officer, Director
  • Jon CopelandDirector
  • Dan RoarkExecutive Officer
  • Marco ChungDirector
Offering amount
$2.7M
Amount sold
$2.6M
Minimum investment
$25K
Proceeds to insiders
$275K
First sale
Feb 2017
Incorporated
Limited Liability Company, Washington, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as Gestalt Diagnostics.

In the news

Frequently asked questions

What does Gestalt Diagnostics do?
Gestalt provides a vendor-neutral digital pathology platform and professional services that enable pathology laboratories and health systems to modernize workflows, integrate AI tools, and manage diagnostic imaging without vendor lock-in. The company serves enterprise hospitals, academic medical centers, and pathology groups seeking interoperable solutions across scanners, laboratory information systems, and AI applications.
Who are Gestalt Diagnostics's investors?
Gestalt Diagnostics's investors include Cowles Ventures, Sun Mountain Capital, Kickstart, Tacoma Venture Fund.
How much funding has Gestalt Diagnostics raised?
Gestalt Diagnostics has disclosed $9.6M raised across 3 rounds.
Where is Gestalt Diagnostics headquartered?
Gestalt Diagnostics is headquartered in Spokane, US.